Pricing Log in Create free account

Ascentage Pharma Group International - Unsponsored ADR (AAPG) vs Nuvation Bio Inc. (NUVB)

Ascentage Pharma Group International - Unsponsored ADR and Nuvation Bio Inc. are both Biotechnology companies. Ascentage Pharma Group International - Unsponsored ADR and Nuvation Bio Inc. are of similar size ($1.5B and $1.4B). Across the 8 metrics below, Ascentage Pharma Group International - Unsponsored ADR leads on 5 and Nuvation Bio Inc. on 3.

Valuation

Metric AAPG NUVB Biotechnology median
P/E — n/m 10.60
P/S — 7.27 9.40
P/B n/m 6.44 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 5.40 9.02
Earnings yield — (9.44%) (32.88%)
Free cash flow yield 0.00% (7.37%) (23.13%)

Profitability

Metric AAPG NUVB Biotechnology median
Gross margin — 85.79% 68.51%
Operating margin — (61.17%) 0.00%
Net margin — (67.38%) 0.00%
Free cash flow margin 0.00% (53.62%) 0.00%
Return on equity 0.00% (49.09%) (51.96%)
Return on assets 0.00% (19.70%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AAPG NUVB Biotechnology median
Revenue growth (TTM) — 654.19% 6.76%
EPS growth (last fiscal year) (177.78%) 71.56% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AAPG NUVB Biotechnology median
Debt to equity 3.70 1.25 0.00
Current ratio 1.22 7.45 4.97
Net debt to EBITDA 0.44 2.26 1.01

Dividend

Metric AAPG NUVB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AAPG NUVB Biotechnology median
Market cap 1.41b 1.48b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack